4.05
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Path Holdings Inc | BPTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 4.05 | 18:10:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.08 | 3.95 | 4.10 | 3.99 | 4.05 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.92 | 4.08 | 0.16 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 864 | 187,924 | $ 4.02 | $ 754,754 | 277,430 | 2.9203 - 7.5826 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:52:47 | 2 | $ 4.00 | USD |
Bio Path Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 18.39M | 4.54M | 4.51M | $ - | $ - | -3.27 | -1.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Bio Path News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BPTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.00 | 4.20 | 3.90 | 4.00 | 142,959 | 0.05 | 1.25% |
| 1 Month | 3.66 | 4.23 | 3.47 | 3.86 | 179,026 | 0.39 | 10.66% |
| 3 Months | 4.13 | 4.70 | 3.12 | 3.69 | 273,456 | -0.08 | -1.94% |
| 6 Months | 5.55 | 6.09 | 3.12 | 4.87 | 600,369 | -1.50 | -27.03% |
| 1 Year | 7.47 | 7.5826 | 2.9203 | 4.94 | 348,773 | -3.42 | -45.78% |
| 3 Years | 43.30 | 73.52 | 1.60 | 15.77 | 579,963 | -39.25 | -90.65% |
| 5 Years | 270.00 | 638.00 | 1.60 | 52.71 | 472,234 | -265.95 | -98.5% |
Bio Path Description
| Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003. |
